IBDEI1X0 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30581,1,2,0)
 ;;=2^Outpt Prolonged Svc,Ea Addl 30 Min
 ;;^UTILITY(U,$J,358.3,30581,1,3,0)
 ;;=3^99355
 ;;^UTILITY(U,$J,358.3,30582,0)
 ;;=99356^^122^1570^1^^^^1
 ;;^UTILITY(U,$J,358.3,30582,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,30582,1,2,0)
 ;;=2^Inpt Prolonged Svc,1st Hr
 ;;^UTILITY(U,$J,358.3,30582,1,3,0)
 ;;=3^99356
 ;;^UTILITY(U,$J,358.3,30583,0)
 ;;=99357^^122^1570^2^^^^1
 ;;^UTILITY(U,$J,358.3,30583,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,30583,1,2,0)
 ;;=2^Inpt Prolonged Svc,Ea Addl 30 Min
 ;;^UTILITY(U,$J,358.3,30583,1,3,0)
 ;;=3^99357
 ;;^UTILITY(U,$J,358.3,30584,0)
 ;;=99358^^122^1570^5^^^^1
 ;;^UTILITY(U,$J,358.3,30584,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,30584,1,2,0)
 ;;=2^Prolonged Svc w/o Patient,1st hr
 ;;^UTILITY(U,$J,358.3,30584,1,3,0)
 ;;=3^99358
 ;;^UTILITY(U,$J,358.3,30585,0)
 ;;=99359^^122^1570^6^^^^1
 ;;^UTILITY(U,$J,358.3,30585,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,30585,1,2,0)
 ;;=2^Prolonged Svc w/o Patient,Ea Addl 30min
 ;;^UTILITY(U,$J,358.3,30585,1,3,0)
 ;;=3^99359
 ;;^UTILITY(U,$J,358.3,30586,0)
 ;;=36430^^122^1571^1^^^^1
 ;;^UTILITY(U,$J,358.3,30586,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,30586,1,2,0)
 ;;=2^Blood Transfusion Service
 ;;^UTILITY(U,$J,358.3,30586,1,3,0)
 ;;=3^36430
 ;;^UTILITY(U,$J,358.3,30587,0)
 ;;=36415^^122^1571^2^^^^1
 ;;^UTILITY(U,$J,358.3,30587,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,30587,1,2,0)
 ;;=2^Routine Venipuncture
 ;;^UTILITY(U,$J,358.3,30587,1,3,0)
 ;;=3^36415
 ;;^UTILITY(U,$J,358.3,30588,0)
 ;;=93784^^122^1572^2^^^^1
 ;;^UTILITY(U,$J,358.3,30588,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,30588,1,2,0)
 ;;=2^Amb BP Monitor 24+ hrs,Intrp & Rpt
 ;;^UTILITY(U,$J,358.3,30588,1,3,0)
 ;;=3^93784
 ;;^UTILITY(U,$J,358.3,30589,0)
 ;;=93786^^122^1572^3^^^^1
 ;;^UTILITY(U,$J,358.3,30589,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,30589,1,2,0)
 ;;=2^Amb BP Monitor 24+ hrs,Rpt Only
 ;;^UTILITY(U,$J,358.3,30589,1,3,0)
 ;;=3^93786
 ;;^UTILITY(U,$J,358.3,30590,0)
 ;;=93788^^122^1572^1^^^^1
 ;;^UTILITY(U,$J,358.3,30590,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,30590,1,2,0)
 ;;=2^Amb BP Analysis & Rpt
 ;;^UTILITY(U,$J,358.3,30590,1,3,0)
 ;;=3^93788
 ;;^UTILITY(U,$J,358.3,30591,0)
 ;;=93790^^122^1572^4^^^^1
 ;;^UTILITY(U,$J,358.3,30591,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,30591,1,2,0)
 ;;=2^Amb BP Review,Intrp & Rpt
 ;;^UTILITY(U,$J,358.3,30591,1,3,0)
 ;;=3^93790
 ;;^UTILITY(U,$J,358.3,30592,0)
 ;;=93770^^122^1572^5^^^^1
 ;;^UTILITY(U,$J,358.3,30592,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,30592,1,2,0)
 ;;=2^Measure Venous Pressure
 ;;^UTILITY(U,$J,358.3,30592,1,3,0)
 ;;=3^93770
 ;;^UTILITY(U,$J,358.3,30593,0)
 ;;=J0636^^122^1573^1^^^^1
 ;;^UTILITY(U,$J,358.3,30593,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,30593,1,2,0)
 ;;=2^Calcitriol per 0.1 MCG
 ;;^UTILITY(U,$J,358.3,30593,1,3,0)
 ;;=3^J0636
 ;;^UTILITY(U,$J,358.3,30594,0)
 ;;=J0713^^122^1573^2^^^^1
 ;;^UTILITY(U,$J,358.3,30594,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,30594,1,2,0)
 ;;=2^Ceftazidime per 500 MG
 ;;^UTILITY(U,$J,358.3,30594,1,3,0)
 ;;=3^J0713
 ;;^UTILITY(U,$J,358.3,30595,0)
 ;;=J1160^^122^1573^5^^^^1
 ;;^UTILITY(U,$J,358.3,30595,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,30595,1,2,0)
 ;;=2^Digoxin up to 0.5 MG
 ;;^UTILITY(U,$J,358.3,30595,1,3,0)
 ;;=3^J1160
 ;;^UTILITY(U,$J,358.3,30596,0)
 ;;=Q0138^^122^1573^9^^^^1
